Ipamorelin Research Vial 5mg

Ipamorelin is a pentapeptide growth hormone secretagogue (GHS) developed by Novo Nordisk that selectively binds to and activates the ghrelin receptor (GHS-R1a) located on pituitary somatotroph cells. As a synthetic analog of ghrelin, it belongs to the GHRP (Growth Hormone Releasing Peptide) family but is distinguished by its exceptional selectivity for GH release over other pituitary hormones. **Mechanism of Action** Ipamorelin functions as an agonist at the GHS-R1a receptor, a G-protein-coupled receptor that initiates a signaling cascade culminating in the pulsatile release of growth hormone from the anterior pituitary. Unlike earlier GHRPs such as GHRP-2 or GHRP-6, ipamorelin demonstrates remarkable specificity—it stimulates GH secretion without significantly elevating cortisol, prolactin, or aldosterone levels. This “cleaner” pharmacological profile has made it a subject of sustained research interest, with 46 PubMed-verified studies supporting its characterization. One of ipamorelin’s most notable properties is its preservation of the body’s natural pulsatile GH release pattern. Its short plasma half-life of approximately two hours means it does not create a sustained supraphysiological elevation but rather augments the amplitude of endogenous GH pulses without disrupting their natural rhythm. This is an important consideration for long-term research applications. **Research Applications** Investigational applications of ipamorelin include the study of GH/IGF-1 axis modulation, lean body composition, nitrogen retention, bone density parameters, and recovery kinetics. Its minimal appetite-stimulating effects distinguish it from other GHRPs like GHRP-6 or GHRP-2, making it a preferred agent in studies where caloric intake confounding must be minimized. In research settings, ipamorelin is frequently investigated in combination with GHRH analogs such as CJC-1295 to explore synergistic GH pulse amplification through complementary signaling pathways—the GHRH pathway and the ghrelin receptor pathway. **Quality Documentation** All batches are analyzed via HPLC for purity verification (≥98%) and mass spectrometry for identity confirmation. Certificate of Analysis available upon request. Product is lyophilized from a sterile-filtered solution and intended for laboratory research use only. Not for human or veterinary administration.